Rapamune 1 mg
Rapamune 1 mg is a medicine authorised by Swissmedic under authorisation number 55804. The authorisation holder is Pfizer AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 December 2001 and the authorisation is valid without a time limit. ATC code L04AH01 places the medicine in the group Immunosuppressants.
| Authorisation number | 55804 |
|---|---|
| Name | Rapamune 1 mg |
| Full name | Rapamune 1 mg, überzogene Tabletten |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AH01 |
| First authorisation | 14 December 2001 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rapamune 1 mg, überzogene Tabletten | B | 14 December 2001 |
| 2 | Rapamune 2 mg, überzogene Tabletten | B | 27 November 2003 |
| 3 | Rapamune 0.5 mg, überzogene Tabletten | B | 15 February 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | L04AH01 | 07.15.0. | B |
| 3 | 100 | Tablette(n) | L04AH01 | 07.15.0. | B |
| 5 | 30 | Tablette(n) | L04AH01 | 07.15.0. | B |
| 7 | 100 | Tablette(n) | L04AH01 | 07.15.0. | B |
| 8 | 30 | Tablette(n) | L04AH01 | 07.15.0. | B |
| 9 | 100 | Tablette(n) | L04AH01 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rapamune 1 mg authorised in Switzerland?
Yes. Rapamune 1 mg is authorised by Swissmedic under authorisation number 55804, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rapamune 1 mg have?
Rapamune 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rapamune 1 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.